| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/18/2010 | CA2734081A1 Combination therapy of hiv fusion/entry inhibitors targeting gp41 |
| 02/18/2010 | CA2733911A1 Use of gdf traps to increase red blood cell levels |
| 02/18/2010 | CA2733898A1 Polyvalent vaccine |
| 02/18/2010 | CA2733775A1 Agent for promoting neuronal differentiation and method therefor |
| 02/18/2010 | CA2733642A1 Anti-il-12/il-23 antibodies |
| 02/18/2010 | CA2733636A1 The use of wnt5-a peptide derivates for the treatment of melanoma and gastric cancer |
| 02/18/2010 | CA2733545A1 Modified biotin-binding protein |
| 02/18/2010 | CA2732882A1 Production, formulation, and uses of stable liquid harpin protein formulations |
| 02/17/2010 | EP2154535A1 Protein scaffolds for antibody mimics and other binding proteins |
| 02/17/2010 | EP2154251A1 Expression system of recombinant proteins with enhanced yield and immunogenicity |
| 02/17/2010 | EP2154250A1 Xenobiotic related induction of gene expression of cytochrome CYP3A4 |
| 02/17/2010 | EP2154249A1 Genes for biosynthesis of tetracycline compounds and uses thereof |
| 02/17/2010 | EP2154248A1 Compounds and methods for diagnosis of tuberculosis |
| 02/17/2010 | EP2154160A1 Hydroxyalkyl starch derivatives |
| 02/17/2010 | EP2154156A2 Analysis of agonist-activity and antagonist-activity to cytokinin receptor |
| 02/17/2010 | EP2154155A2 Analysis of agonist-activity and antagonist-activity to cytokinin receptor |
| 02/17/2010 | EP2154154A1 G-protein-conjugated receptor having altered ligand affinity, and use thereof |
| 02/17/2010 | EP2154153A1 Mutant alpha-synuclein, and methods using same |
| 02/17/2010 | EP2154152A1 Use of Conkunitzin-S1 for the modulation of glucose-induced insulin secretion |
| 02/17/2010 | EP2154151A2 Clostridial toxin activatable clostridial toxins |
| 02/17/2010 | EP2154150A1 Genes for biosynthesis of tetracycline compounds and uses thereof |
| 02/17/2010 | EP2154149A1 A truncated l1 protein of human papillomavirus 6 |
| 02/17/2010 | EP2154148A1 A truncated l1 protein of human papillomavirus 11 |
| 02/17/2010 | EP2154147A1 A truncated l1 protein of human papillomavirus 16 |
| 02/17/2010 | EP2154146A1 Use of african swine pest haemoglutinin as an adjuvant |
| 02/17/2010 | EP2154145A2 Dimerized peptide |
| 02/17/2010 | EP2153846A1 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immonostimulatory molecule |
| 02/17/2010 | EP2153843A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/17/2010 | EP2153840A1 Therapeutic agent and detection reagent for arteriosclerotic disease which targets for thallusin |
| 02/17/2010 | EP2153228A1 Methods for detecting cardiac damage |
| 02/17/2010 | EP2152887A1 Yield enhancement in plants by modulation of garp transcripton factor zmrr10_p |
| 02/17/2010 | EP2152884A1 Methods and means for producing glycoproteins with altered glycosylation pattern in higher plants |
| 02/17/2010 | EP2152882A2 Cells expressing chimeric proteins and assays using such cells |
| 02/17/2010 | EP2152881A2 Rumc peptides with antimicrobial activity |
| 02/17/2010 | EP2152743A2 Cross-linked collagen and uses thereof |
| 02/17/2010 | EP2152741A2 Peptides with improved properties having the biological activity of vasoactive intestinal peptide (vip) and their use for the treatment of lung diseases |
| 02/17/2010 | EP2152740A1 Products for altering il-33 activity and methods therefor |
| 02/17/2010 | EP2152739A2 Mutants of interleukin-1 receptor antagonist and uses thereof |
| 02/17/2010 | EP2152737A2 Methods of treating, diagnosing and detecting fgf21-associated disorders |
| 02/17/2010 | EP2152736A1 Complement factor h-derived short consensus repeat-antibody constructs |
| 02/17/2010 | EP2152735A1 Method for producing mature vwf from vwf pro-peptide |
| 02/17/2010 | EP2152734A1 Yield enhancement in plants by modulation of maize mads box transcription factor zmm28 |
| 02/17/2010 | EP2152733A2 Yield enhancement in plants by modulation of maize alfins |
| 02/17/2010 | EP2152732A1 A modified secretion system to increase expression of polypeptides in bacteria |
| 02/17/2010 | EP2152731A2 Klebsiella antigens |
| 02/17/2010 | EP2152730A2 Enhancement of glycoprotein incorporation into virus-like particles |
| 02/17/2010 | EP2152729A1 Hpv epitopes targeted by t cells infiltrating cervical malignancies for use in vaccines |
| 02/17/2010 | EP2152727A1 Peptide standards |
| 02/17/2010 | EP2152308A1 New indications for anti- il-i-beta therapy |
| 02/17/2010 | EP2152298A1 Modified nucleotide sequence encoding glucagon-like peptide-1 (glp-1) |
| 02/17/2010 | EP2152297A1 Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders |
| 02/17/2010 | EP2152292A1 Angiogenesis inhibitor comprising meteorin as an active ingredient |
| 02/17/2010 | EP2152276A1 Screening assay to identify correctors of protein trafficking defects |
| 02/17/2010 | EP1644504B1 Factor vii or viia gla domain variants |
| 02/17/2010 | EP1627049B1 Novel trichoderma genes |
| 02/17/2010 | EP1578919B1 Endogenous retrovirus up-regulated in prostate cancer |
| 02/17/2010 | EP1443111B1 Desmin gene having novel point mutation causative of dilated cardiomyopathy |
| 02/17/2010 | EP1404816B1 Human hepatoma cell lines, methods for obtaining same and uses thereof |
| 02/17/2010 | EP1263954B1 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/17/2010 | EP1240186B1 Improvements in or relating to immune responses to hiv |
| 02/17/2010 | EP1200132B2 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines |
| 02/17/2010 | EP1133560B1 Human parathyroid hormone modifications, preparation and use |
| 02/17/2010 | EP1117783B1 Gene expressed in prostate cancer |
| 02/17/2010 | CN101652387A Alk1受体和配体拮抗剂及其用途 Alk1 receptor and ligand antagonists and their use |
| 02/17/2010 | CN101652386A OB-FOLD used as scaffold for engineering new specific binders |
| 02/17/2010 | CN101652385A replikin peptides and uses thereof |
| 02/17/2010 | CN101652384A A polypeptide being capable of increasing the production of L-methionine, a microorganism that overexpresses said polypeptide and a process of preparing L-methionine in high yield using same |
| 02/17/2010 | CN101649351A Methods for diagnosis and therapy of cancer and composition useful therein |
| 02/17/2010 | CN101648996A Anti-myocardial remodelling polypeptide, preparation method thereof, preparations and application thereof in preparation of anti-myocardial remodelling medicament |
| 02/17/2010 | CN101648995A Human recombination Reg4 protein and coding gene thereof as well as preparation method thereof |
| 02/17/2010 | CN100590196C Branched neutral amino acid transporters acting as single molecule |
| 02/17/2010 | CN100590133C Growth hormone and serum albumni recombinant fusion protein |
| 02/17/2010 | CN100590132C Inhibitors of MEMAPSIN2 and use thereof |
| 02/17/2010 | CN100590131C Methods and compounds for the targeting of protein to exosomes |
| 02/17/2010 | CN100590130C Anticancer active peptide |
| 02/17/2010 | CN100590129C Human ring protein application |
| 02/17/2010 | CN100589845C Anti-neovasculature preparations for cancer |
| 02/17/2010 | CN100589839C Polypeptide and medicament composition containing polypeptide |
| 02/16/2010 | USRE41133 Glucagon-like peptide-1 crystals |
| 02/16/2010 | USRE41129 Cytokine zalpha11 ligand polynucleotides |
| 02/16/2010 | US7664625 Molecular modeling for metalloproteins |
| 02/16/2010 | US7663036 Plants and seeds of hybrid corn variety CH945822 |
| 02/16/2010 | US7663031 Maize variety PHW2M |
| 02/16/2010 | US7663018 Animal model involving transgenic manipulation of amyloid precursor protein; useful for testing potential therapeutic agents for the treatment of neurodegenerative disorders, in particular Alzheimer's disease; drug screening |
| 02/16/2010 | US7663017 animal models having disrupted genes, used to test the immunogenicity of human vaccine candidates; drug screening |
| 02/16/2010 | US7662934 Process for reducing biomass-biomass or biomass—resin interactions |
| 02/16/2010 | US7662933 Pegylated granulocyte colony stimulating factor (G-CSF) to treat a hematopoietic disorder related to reduced neutrophil count, such as infectious disease, sepsis, or a result of radiotherapy or chemotherapy |
| 02/16/2010 | US7662932 Endothelial growth factor; isolated polypeptide; stimulate cell proliferation, neovascularization, vascular system permeability |
| 02/16/2010 | US7662923 Modified vitamin K-dependent polypeptides |
| 02/16/2010 | US7662922 Canola protein isolate compositions |
| 02/16/2010 | US7662921 Methods of treating viral disorders |
| 02/16/2010 | US7662920 Made by inter-molecularly crosslinking the fluorescent protein such as a phycobiliprotein with itself; easier to purify; assay sensitivity; use in labeling and detection of biomolecules; crosslinker such as disuccinimidyl suberate |
| 02/16/2010 | US7662919 Notch-based fusion proteins and uses thereof |
| 02/16/2010 | US7662917 Human sarcoma-associated antigens |
| 02/16/2010 | US7662916 Modified HIV Env polypeptides |
| 02/16/2010 | US7662913 Inclusion body tags for use as molecular beacon in identification of heterologous polypeptides |
| 02/16/2010 | US7662794 DNA enzyme to inhibit plasminogen activator inhibitor-1 |
| 02/16/2010 | US7662782 Melanocortin 1 receptor selective compounds |
| 02/16/2010 | US7662775 Method for screening agents for the treatment of diabetes |
| 02/16/2010 | US7662774 Treating syndromes associated with acute or chronic inflammation where activation of Factor VII, Xa and tissue factor expression is involved |